SCHEMBL2801433

SCHEMBL2801433

CS(=O)(=O)NC(=O)c1cnn2c(NCc3cccc(Cl)c3)c(C(=O)N3CCC(c4ccccc4)CC3)cnc12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.39
MAPT P10636 2/20 0.39
CCKBR P32239 1/20 0.39
KDM4E B2RXH2 3/20 0.39
HPGD P15428 2/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
AVPR1A P37288 1/20 0.38
EGLN1 Q9GZT9 3/20 0.38
ALDH1A1 P00352 2/20 0.38
SCN9A Q15858 2/20 0.38
TPSAB1 Q15661 2/20 0.38
THRB P10828 1/20 0.37
MGLL Q99685 1/20 0.36
HTT P42858 1/20 0.36
ADRB2 P07550 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2799687 0.92 STAT6 (0.40) KDM4EHPGDLMNAEGLN1ALDH1A1
SCHEMBL2800864 0.92 CCR1 (0.42) TP53THRB
SCHEMBL2800890 0.91 NTRK1 (0.40) TP53EGLN1ALDH1A1SCN9ATPSAB1
SCHEMBL2802134 0.91 AVPR1A (0.42) TP53MAPTCCKBRKDM4EHPGD
SCHEMBL2799741 0.90 CHRM4 (0.40) TP53MAPTKDM4ELMNATSHR
SCHEMBL2803544 0.89 TPSAB1 (0.40) TP53MAPTKDM4EHPGDALDH1A1
SCHEMBL2802186 0.88 VNN1 (0.43) KDM4EHPGDHSD17B10ALDH1A1TPSAB1
SCHEMBL2802391 0.88 SMN1; SMN2 (0.41) TP53MAPTKDM4EHPGDLMNA
SCHEMBL2802693 0.87 TP53 (0.41) TP53MAPTLMNATSHREGLN1
SCHEMBL2798553 0.87 THRB (0.37) TP53KDM4EHPGDLMNAEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 TP53 241/4885MAPT 2533/4885CCKBR 4859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.